Fine-needle Biopsy Combined With Macroscopic On-site Evaluation for Diagnosis of Solid Pancreatic Lesions

Exclusion Criteria

• •(Before the trial, participants could not be enrolled if they met any of the following requirements)
• •1. contraindications to endoscopy, such as severe cardiovascular and cerebrovascular diseases;
• •2. bleeding coagulation dysfunction (prothrombin international normalized ratio ≥1.5, platelet count ≤ 50 000) or use of antiplatelet drugs;
• •3. confirmed pregnancy or possible pregnancy;
• •4. pathological diagnosis has been obtained by other methods;
• •5. refuse to participate in the study, are participating in another observational clinical trial, or have participated in another clinical trial within 60 days.
• •6. other situations where EUS-FNB could not be performed.